Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
MASSDEVICE ON CALL — Recent data exposures from the Centers for Medicare & Medicaid have raised eyebrows about the cost of U.S. healthcare and variability among care providers, but Biomet CEO Jeffrey Binder insists that medical devices are not to blame.
In a new editorial written for Philly.com, Binder defended the industry and its role in the ever-rising cost of U.S. healthcare, writing that medtech more often helps curb costs by keeping people healthier longer and out of the hospital. Read more
Acquisition activity among medical device companies surged some 200% by value and 111% by volume during the 1st quarter compared with the same period last year, with medtech firms seeking both tuck-ins and more transformative deals aimed at navigating the new healthcare landscape, according to a PricewaterhouseCoopers report.
There were 19 acquisition deals worth roughly $2 billion during the quarter, according to the PwC report, “Pharmaceutical and Life Sciences Deals Insights Quarterly.” Read more
Medical device industry giant Medtronic is reportedly in talks to acquire wearable sensor maker Corventis in a deal worth upward of $150 million, according to a report from MobiHealthNews.
The companies have yet to announce any agreement, but the report claims news of the acquisition will be made in the coming weeks. Read more